Methylprednisolone With Endovascular Thrombectomy for Large Ischemic Stroke
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1614 participants.
Also called NCT06870448
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,614 participants
- Registry
-
NCT06870448
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06870448. Randomized; quadruple masking; primary purpose treatment. Start 2025-04 (anticipated); primary completion 2029-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Methylprednisolone With Endovascular Thrombectomy for Large Ischemic Stroke
- Acronym
- MATCH
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- Methyprednisolone sodium succinate
- Intervention (Drug)
- Placebo
- Lead sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Record details
- Record id
cardio:ct-nct06870448- Content hash
660c812bab9b4e4c181b6f9500bf74fe930c67b627d3fea02c27a722c00aadd5